Association between Type of Cataract According to LOCS Classification with Diabetes Mellitus
Type of cataract and Diabetes Mellitus
DOI:
https://doi.org/10.54393/pbmj.v5i7.502Keywords:
Posterior Sub Capsular Cataract, Diabetes Mellitus, Cortical Cataract, Nuclear CataractAbstract
Prevalence of diabetes mellitus has increased over time. DM has several adverse effects on body, out of which cataract is the most common ocular complication. Cataract is found to be more common in patients with diabetes mellitus due to changes in the metabolism of body. Objectives: To determine the association of type of cataract according to LOCS classification with diabetes mellitus. Methods: The age of the patients was in the range of 25-80 years old. The inclusion criteria were the diabetic patients having the diabetic history of more than 8 years. Patients who were older than 80 years old and who had a history of any systemic disease were disqualified from the trial. All of the patients who were included underwent thorough eye examination. Results: 98 patients were included in the study having positive history of diabetes mellitus. The most common kind of cataract in people with diabetes is PSCC. There were 51 participants with posterior sub-capsular cataract (PSCC) (52.0 percent). This was followed by nuclear sclerosis cataract in twenty (20.04%) patients and cortical cataract in twelve (12.2%) individuals. In contrast, diabetic patients only experienced posterior polar cataract in seven (7.1%) patients and nuclear sclerosis and PSCC in the remaining eight (8.1%) patients. Conclusions: Diabetic mellitus patients should be checked for PSCC, which can impair vision, particularly in bright light, or during the day
References
Kanski JJ. Clinical ophthalmology: a systematic approach. Elsevier Brasil; 2007.
Friedlander M. Fibrosis and diseases of the eye. The Journal of clinical investigation. 2007 Mar; 117(3):576-86. doi: 10.1172/JCI31030
Lathika V and Ajith T. Association of grade of cataract with duration of diabetes, age and gender in patients with type II diabetes mellitus. International Journal of Advances in Medicine. 2016 Apr; 3(2):304-8. doi: 10.18203/2349-3933.ijam20161080
Gupta SK, Selvan VK, Agrawal SS, Saxena R. Advances in pharmacological strategies for the prevention of cataract development. Indian Journal of Ophthalmology. 2009 May-Jun; 57(3):175-83. doi: 10.4103/0301-4738.49390
Hyman L, Wu SY, Connell AM, Schachat A, Nemesure B, Hennis A, et al. Prevalence and causes of visual impairment in The Barbados Eye Study. Ophthalmology. 2001 Oct; 108(10):1751-6. doi: 10.1016/s0161-6420(01)00590-5
Ang MJ and Afshari NA. Cataract and systemic disease: A review. Clinical and Experimental Ophthalmology. 2021 Mar; 49(2):118-127. doi: 10.1111/ceo.13892
Patel PM, Jivani N, Malaviya S, Gohil T, Bhalodia Y. Cataract: A major secondary diabetic complication. International Current Pharmaceutical Journal. 2012 Jun; 1(7):180-5. doi: 10.3329/icpj.v1i7.10813
Dineen B, Bourne RR, Jadoon Z, Shah SP, Khan MA, Foster A, et al. Pakistan National Eye Survey Study Group. Causes of blindness and visual impairment in Pakistan. The Pakistan national blindness and visual impairment survey. British Journal of Ophthalmology. 2007 Aug; 91(8):1005-10. doi: 10.1136/bjo.2006.108035
Jadoon Z, Shah SP, Bourne R, Dineen B, Khan MA, Gilbert CE, et al. Pakistan National Eye Survey Study Group. Cataract prevalence, cataract surgical coverage and barriers to uptake of cataract surgical services in Pakistan: the Pakistan National Blindness and Visual Impairment Survey. British Journal of Ophthalmology. 2007 Oct; 91(10):1269-73. doi: 10.1136/bjo.2006.106914.
American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021 Jan; 44:S15-S33. doi: 10.2337/dc21-S002
Kim SI and Kim SJ. Prevalence and risk factors for cataracts in persons with type 2 diabetes mellitus. Korean Journal of Ophthalmology. 2006 Dec; 20(4):201-4. doi: 10.3341/kjo.2006.20.4.201
Dervenis N, Praidou A, Dervenis P, Chiras D, Little B. Visual Acuity Outcomes after Phacoemulsification in Eyes with Good Visual Acuity before Cataract Surgery. Medical Principles and Practice. 2021; 30(3):285-291. doi: 10.1159/000514662
Rotimi C, Daniel H, Zhou J, Obisesan A, Chen G, Chen Y, et al. Prevalence and determinants of diabetic retinopathy and cataracts in West African type 2 diabetes patients. Ethnicity and Disease. 2003 Summer; 13(2 Suppl 2):S110-7.
Olafsdottir E, Andersson DK, Stefánsson E. The prevalence of cataract in a population with and without type 2 diabetes mellitus. Acta Ophthalmologica. 2012 Jun; 90(4):334-40. doi: 10.1111/j.1755-3768.2011.02326.x
Kyselova Z, Stefek M, Bauer V. Pharmacological prevention of diabetic cataract. Journal of Diabetic Complications. 2004 Apr; 18(2):129-40. doi: 10.1016/S1056-8727(03)00009-6
Raman R, Pal SS, Adams JS, Rani PK, Vaitheeswaran K, Sharma T. Prevalence and risk factors for cataract in diabetes: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study, report no. 17. Investigative Ophthalmology and Visual Science. 2010 Dec; 51(12):6253-61. doi: 10.1167/iovs.10-5414
Rooban BN, Lija Y, Biju PG, Sasikala V, Sahasranamam V, Abraham A. Vitex negundo attenuates calpain activation and cataractogenesis in selenite models. Experimental Eye Research. 2009 Mar; 88(3):575-82. doi: 10.1016/j.exer.2008.11.020
Dowler JG, Hykin PG, Hamilton AM. Phacoemulsification versus extracapsular cataract extraction in patients with diabetes. Ophthalmology. 2000 Mar; 107(3):457-62. doi: 10.1016/s0161-6420(99)00136-0
Prokofyeva E, Wegener A, Zrenner E. Cataract prevalence and prevention in Europe: a literature review. Acta Ophthalmologica. 2013 Aug; 91(5):395-405. doi: 10.1111/j.1755-3768.2012.02444.x
Liu YC, Wilkins M, Kim T, Malyugin B, Mehta JS. Cataracts. Lancet. 2017 Aug; 390(10094):600-612. doi: 10.1016/S0140-6736(17)30544-5
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Pakistan BioMedical Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments editor@pakistanbmj.com